The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

Share Price Information for Apax Global Alpha (APAX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 151.60
Bid: 151.00
Ask: 152.00
Change: 1.20 (0.80%)
Spread: 1.00 (0.662%)
Open: 150.80
High: 152.80
Low: 150.80
Prev. Close: 150.40
APAX Live PriceLast checked at -
Apax Global Alpha is an Investment Trust

To provide shareholders with capital appreciation from our investment portfolio and regular dividends.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Apax Funds’ Valuations and Credit Facility update

2 Feb 2023 07:00

RNS Number : 6586O
Apax Global Alpha Limited
02 February 2023
 

 

(LSE: APAX)

Apax Global Alpha Limited

Apax Funds' Valuations and Credit Facility update

 

Apax Global Alpha Limited ("AGA" or the "Company") has a portfolio of Private Equity and Derived Investments. Under its Private Equity strategy, AGA is a limited partner in certain Private Equity funds advised by Apax Partners LLP (the "Apax Funds").

 

Apax Funds' valuations update

 

AGA has received the Apax Funds' valuations for the Private Equity portfolio as at 31 December 2022 which are set out below at an individual fund level (net of relevant fees and carried interest estimates)1.

 

Details on the composition and valuation of the AGA portfolio as at 31 December 2022 (which may differ to those shown in the table below due to the various holding structures through which AGA invests) will be included in AGA's 2022 Full Year Results, being released on 2 March 2023.

 

Valuations for the Apax Funds to which AGA has an exposure, have reported the following movements for the period from 30 September 2022 to 31 December 2022:

 

 

Valuation at 30.09.222

Capital Calls

(Distributions)

Unrealised Gain / (Loss)

Valuation at 31.12.222

Like-for-like

% change3

Apax XI EUR €m

 -

 -

 -

 (8)

 (8)

nm4

Apax XI USD $m

 -

 -

 -

 (42)

 (42)

nm4

Apax X EUR €m

 1,593

 528

 -

 (100)

 2,021

-5%

Apax X USD $m

 5,169

 2,072

 -

275

 7,516

4%

Apax IX EUR €m

 3,038

 -

 (487)

 (204)

 2,347

-7%

Apax IX USD $m

 8,261

 -

 (1,404)

 119

 6,976

1%

Apax VIII EUR €m

 956

 -

 (95)

 (142)

 719

-15%

Apax VIII USD $m

 1,105

 -

 (122)

 (89)

 894

-8%

Apax Europe VII €m

 222

 -

 -

 (102)

 120

-46%

Apax Europe VI €m

 309

 -

 -

 (36)

 273

-12%

Apax Digital $m

 1,076

 51

 -

 21

 1,148

2%

Apax Digital II $m

 (48)

 68

 -

 (1)

 19

-5%

Apax Global Impact $m

 (6)

 -

 -

 (18)

 (24)

nm4

AMI $m

 435

 1

 (6)

 (8)

 422

-2%

AMI II $m

 -

 -

 -

 (7)

 (7)

nm4

 

The above numbers exclude the sale of Duck Creek Technologies, an Apax VIII portfolio company, which was announced by AGA on 13 January 2023. The transaction values AGA's current look-through investment in Duck Creek at approximately €32m. This represents an uplift of 46% of to last Unaffected Valuations5 and an uplift of c.€10m (c.€0.02 per share) in the Adjusted Net Asset Value ("Adjusted NAV") of AGA at 30 September 2022, prior to any closing adjustments, fees, costs and carried interest.

 

AGA Credit Facility update

 

AGA also announces an update on its €250 million multi-currency revolving credit facility (the "Facility").

 

AGA has had a revolving credit facility with Credit Suisse AG, London Branch since November 2018 which featured an evergreen term, with a rolling minimum notice period of two years. Following the formal receipt of notice, the Facility has reverted to a conventional fixed-term arrangement with an expiry date of 10 January 2025.

 

The Board and Investment Manager are confident that AGA's prudent approach to balance sheet management provides comfort over the existing and planned commitments. The Facility was undrawn at 31 December 2022 and currently remains undrawn. The Company's Derived Investments portfolio of €390.4 million (as at 30 September 2022) provides additional capital resources and flexibility.

 

Commenting on the performance, Ralf Gruss, COO of Apax, said:

 

"Performance in Private Equity was resilient overall in the face of challenging and volatile markets, especially for the larger funds to which AGA is exposed. In 2022, the Apax Funds continued to achieve attractive uplifts to prior valuations on exits. We continue to believe the Apax Funds' strategy of diversification, investing in businesses with strong economic motors, and focusing on generating 'alpha' through business transformation, is well suited to the current macro environment."

 

Contact details

 

Investor Relations - AGA

Lorraine Rees

T: +44 7889 089 220

E: Lorraine.rees@apax.com

Footnotes

 

1

 

2

AGA holds exposures to the Apax Funds via various individual holdings which also have different fee structures

 

Where relevant, the valuations are expressed net of any estimated carried interest payable should the funds hypothetically be liquidated as at 30 September 2022 and 31 December 2022 respectively

3

The like-for-like change represents the change in valuation from the prior to the current reporting date, adjusting for changes due to calls and distributions. Any calls made during the period are added to the prior valuation and distributions are added back to the current valuation

 

4

Not meaningful ("nm") as these funds have not yet called investors and have utilised their capital call facilities to fund investments and expenses

5

Unaffected Valuation is determined as the fair value in the last quarter before exit, when valuation is not affected by the exit process (i.e. because an exit was signed, or an exit was sufficiently close to being signed that the Apax Funds incorporated the expected exit multiple into the quarter end valuation)

 

Notes

 

1

Note that references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". References to Apax Partners LLP have been abbreviated to "Apax" or "the Investment Adviser"

 

2

Please be advised that this announcement may contain inside information as stipulated under the Market Abuse Regulations (EU) NO. 596/2014 ("MAR")

 

3

This announcement is not for release, publication or distribution, directly or indirectly, in whole or in part, into or within the United States or to "US persons" (as defined in Regulation S under the United States Securities Act of 1933, as amended (the "Securities Act")) or into or within Australia, Canada, South Africa or Japan. Recipients of this announcement in jurisdictions outside the UK should inform themselves about and observe any applicable legal requirements in their jurisdictions. In particular, the distribution of the announcement may be restricted by law in certain jurisdictions

 

4

The information presented herein is not an offer for sale within the United States of any equity shares or other securities of Apax Global Alpha Limited ("AGA"). AGA has not been and will not be registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition, AGA's shares (the "Shares") have not been and will not be registered under the Securities Act or any other applicable law of the United States. Consequently, the Shares may not be offered or sold or otherwise transferred within the United States, or to, or for the account or benefit of, US Persons, except pursuant to an exemption from the registration requirements of the Securities Act and under circumstances which will not require AGA to register under the Investment Company Act. No public offering of the Shares is being made in the United States

 

5

This announcement may include forward-looking statements. The words "expect", "anticipate", "intends", "plan", "estimate", "aim", "forecast", "project" and similar expressions (or their negative) identify certain of these forward-looking statements. These forward-looking statements are statements regarding AGA's intentions, beliefs or current expectations concerning, among other things, AGA's results of operations, financial condition, liquidity, prospects, growth and strategies. The forward-looking statements in this presentation are based on numerous assumptions regarding AGA's present and future business strategies and the environment in which AGA will operate in the future. Forward-looking statements involve inherent known and unknown risks, uncertainties and contingencies because they relate to events and depend on circumstances that may or may not occur in the future and may cause the actual results, performance or achievements of AGA to be materially different from those expressed or implied by such forward looking statements. Many of these risks and uncertainties relate to factors that are beyond AGA's ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behaviour of other market participants, the actions of regulators and other factors such as AGA's ability to continue to obtain financing to meet its liquidity needs, changes in the political, social and regulatory framework in which AGA operates or in economic or technological trends or conditions. Past performance should not be taken as an indication or guarantee of future results, and no representation or warranty, express or implied, is made regarding future performance. AGA expressly disclaims any obligation or undertaking to release any updates or revisions to these forward-looking statements to reflect any change in AGA's expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based after the date of this announcement, or to update or to keep current any other information contained in this announcement. Accordingly, undue reliance should not be placed on the forward-looking statements, which speak only as of the date of this announcement

 

 

About Apax Global Alpha Limited

 

AGA is a Guernsey registered closed-ended collective investment scheme incorporated as a non-cellular company that listed on the London Stock Exchange on 15 June 2015. It is regulated by the Guernsey Financial Services Commission.

 

AGA's objective is to provide shareholders with capital appreciation from its investment portfolio and regular dividends. The Company is targeting an annualised Total Return, across economic cycles, of 12-15% (net of fees and expenses) including a dividend yield of 5% of Net Asset Value.

 

The investment policy of the Company is to make Private Equity investments in Apax Funds, and Derived Investments which are investments in equities and debt derived from the insights gained via Apax Partners' Private Equity activities. The Company's portfolio is expected to be allocated in approximately equal proportions between Private Equity and Derived Investments, although the investment mix will fluctuate over time due to market conditions, investment opportunities, cash flow requirements, the dividend policy and other factors. Further information regarding the Company and its publications are available on the Company's website at www.apaxglobalalpha.com.

 

About Apax Partners LLP

 

Apax Partners LLP ("Apax") is a leading global private equity advisory firm. For 50 years, Apax has worked to inspire growth and ideas that transform businesses. The firm has raised and advised funds with aggregate commitments of more than $60 billion. The Apax Funds invest in companies across four global sectors of Tech, Services, Healthcare, and Internet/Consumer. These funds provide long-term equity financing to build and strengthen world-class companies. For further information about Apax, please visit www.apax.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAEAFEAKDEAA
Date   Source Headline
14th Mar 20197:00 amRNSNotice of AGM
13th Mar 20196:05 pmRNSDirector/PDMR Shareholding
5th Mar 20197:00 amRNSUpdated Key Information Document
5th Mar 20197:00 amRNS2018 Annual Dividend
5th Mar 20197:00 amRNS2018 Annual Report and Accounts
5th Mar 20197:00 amRNS2018 Final Results
26th Feb 201911:42 amRNSExits from Exact Software and AssuredPartners
29th Jan 20197:00 amRNSApax Funds' Valuations as at 31 December 2018
21st Dec 20181:48 pmRNSDirector/PDMR Shareholding
21st Dec 201812:09 pmRNSInclusion in FTSE 250 Index
19th Dec 20186:30 pmRNSShire
27th Nov 201810:00 amRNSPDMR Dealing - Share Transfers
23rd Nov 20183:07 pmRNSDirector Dealings - Chris Ambler
14th Nov 20187:00 amRNSNotice of Annual Results
7th Nov 20187:00 amRNSNew revolving credit facility
7th Nov 20187:00 amRNSQuarterly results for the period ended 30 Sep 2018
13th Sep 20184:29 pmRNSDirector Dealings - Chris Ambler
5th Sep 20185:12 pmRNSNotice of Quarterly Results 30 Sept 2018
14th Aug 20187:00 amRNS2018 Interim Dividend
14th Aug 20187:00 amRNS2018 Interim Report and Accounts
14th Aug 20187:00 amRNS2018 Interim Results Highlights
31st Jul 20187:00 amRNSApax Funds' Valuations as at 30 June 2018
18th Jul 20183:00 pmRNSHolding(s) in Company
3rd Jul 201810:00 amRNSDirectorate Change
2nd Jul 20183:00 pmRNSDirector Declaration
14th Jun 20187:00 amRNSNotice of Interim Results 2018
6th Jun 20187:00 amRNSAGA Investor Day
23rd May 201810:00 amRNSEU GDPR Data Privacy Notices
3rd May 20187:00 amRNSQuarterly results for 31 March 2018
1st May 20183:04 pmRNSResult of AGM
26th Apr 201812:47 pmRNSDirectorate Change
16th Apr 20187:25 amRNSNotice of Investor Day
19th Mar 20184:46 pmRNSDirector Declaration
19th Mar 201812:00 pmRNSNotice of AGM
14th Mar 20182:45 pmRNSNotice of Quarterly Results Q1 2018
6th Mar 20187:00 amRNS2017 Annual Dividend Announcement
6th Mar 20187:00 amRNS2017 Annual Report and Accounts
6th Mar 20187:00 amRNSUpdated Key Information Document
6th Mar 20187:00 amRNS2017 Final Results
31st Jan 20185:25 pmRNSDirector/PDMR Shareholding
30th Jan 20187:00 amRNSApax Funds' Valuations as at 31 December 2017
4th Jan 20185:09 pmRNSDirectorate Change - Sarah Evans
2nd Jan 201812:00 pmRNSPublication of Key Information Document
15th Dec 20172:06 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSNotice of Annual Results
1st Nov 20177:00 amRNSQ3 2017 Results Highlights
11th Sep 20177:00 amRNS3Q17 Financial Highlights
31st Aug 20172:57 pmRNSAGA's FTSE Index Inclusion
17th Aug 20177:00 amRNS2017 Interim Dividend
17th Aug 20177:00 amRNS2017 Interim Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.